These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12095664)
1. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Heil SH; Holmes HW; Bickel WK; Higgins ST; Badger GJ; Laws HF; Faries DE Drug Alcohol Depend; 2002 Jul; 67(2):149-56. PubMed ID: 12095664 [TBL] [Abstract][Full Text] [Related]
2. A comparison of subjective, psychomotor and physiological effects of a novel muscarinic analgesic, LY297802 tartrate, and oral morphine in occasional drug users. Petry NM; Bickel WK; Huddleston J; Tzanis E; Badger GJ Drug Alcohol Depend; 1998 Apr; 50(2):129-36. PubMed ID: 9649964 [TBL] [Abstract][Full Text] [Related]
3. Abuse liability assessment of atomoxetine in a drug-abusing population. Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639 [TBL] [Abstract][Full Text] [Related]
5. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR Pharmacol Biochem Behav; 2011 Nov; 100(1):40-7. PubMed ID: 21802442 [TBL] [Abstract][Full Text] [Related]
6. Absence of psychostimulant effects of a supratherapeutic dose of tianeptine: a placebo-controlled study versus methylphenidate in young healthy volunteers. Bernard K; Penelaud PF; Mocaër E; Donazzolo Y J Clin Psychopharmacol; 2011 Aug; 31(4):441-8. PubMed ID: 21694627 [TBL] [Abstract][Full Text] [Related]
7. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial. Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134 [TBL] [Abstract][Full Text] [Related]
8. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131 [TBL] [Abstract][Full Text] [Related]
9. Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants. Cantilena L; Kahn R; Duncan CC; Li SH; Anderson A; Elkashef A J Addict Med; 2012 Dec; 6(4):265-73. PubMed ID: 22987022 [TBL] [Abstract][Full Text] [Related]
10. Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users. Schoedel KA; Meier D; Chakraborty B; Manniche PM; Sellers EM Clin Pharmacol Ther; 2010 Jul; 88(1):69-78. PubMed ID: 20520602 [TBL] [Abstract][Full Text] [Related]
11. A pharmacological analysis of stimulant-induced increases in smoking. Vansickel AR; Stoops WW; Glaser PE; Rush CR Psychopharmacology (Berl); 2007 Aug; 193(3):305-13. PubMed ID: 17447052 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression. Liang EF; Lim SZ; Tam WW; Ho CS; Zhang MW; McIntyre RS; Ho RC Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30127314 [TBL] [Abstract][Full Text] [Related]
13. Abuse liability of flunitrazepam among methadone-maintained patients. Farré M; Terán MT; Roset PN; Mas M; Torrens M; Camí J Psychopharmacology (Berl); 1998 Dec; 140(4):486-95. PubMed ID: 9888625 [TBL] [Abstract][Full Text] [Related]
14. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sangal RB; Owens J; Allen AJ; Sutton V; Schuh K; Kelsey D Sleep; 2006 Dec; 29(12):1573-85. PubMed ID: 17252888 [TBL] [Abstract][Full Text] [Related]
16. Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task. Maguire DR; France CP Psychopharmacology (Berl); 2019 Jun; 236(6):1959-1972. PubMed ID: 30798404 [TBL] [Abstract][Full Text] [Related]
17. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843 [TBL] [Abstract][Full Text] [Related]
18. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults. Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936 [TBL] [Abstract][Full Text] [Related]
19. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [TBL] [Abstract][Full Text] [Related]
20. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. Stoops WW; Glaser PE; Fillmore MT; Rush CR J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]